IQVIA Holdings Inc.
IQV
Classificação em ações
#557
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Preço da ação
$267.50
Última sincronização: 2026-10-20
Valor de mercado
$44.03B
Variação (1 dia)
0.62%
Variação (1 ano)
22.33%
País
US
Negociar IQVIA Holdings Inc. (IQV)
Categoria
Healthcare
Número de ações em circulação para IQVIA Holdings Inc. (IQV)
Número de ações em circulação em June 2026: 167.20M
De acordo com os últimos relatórios financeiros e o preço das ações da IQVIA Holdings Inc., o número atual de ações em circulação é 167.20M. No final de December 2024, a empresa tinha 181.30M ações em circulação. O número de ações em circulação é geralmente afetado por desdobramentos de ações e recompra de ações.
Histórico de ações em circulação da IQVIA Holdings Inc. (IQV) de 2010 a 2026
Ações em circulação no final de cada ano
| Ano | Ações em circulação | Alterar |
|---|---|---|
| 2026 (TTM) | 167.20M | -2.73% |
| 2025 | 171.90M | -5.18% |
| 2024 | 181.30M | -1.36% |
| 2023 | 183.80M | -2.03% |
| 2022 | 187.60M | -1.99% |
| 2021 | 191.40M | 0.05% |
| 2020 | 191.30M | -1.95% |
| 2019 | 195.10M | -4.22% |
| 2018 | 203.70M | -6.47% |
| 2017 | 217.80M | 46.08% |
| 2016 | 149.10M | 21.18% |
| 2015 | 123.04M | -3.87% |
| 2014 | 127.99M | 3.10% |
| 2013 | 124.15M | -1.05% |
| 2012 | 125.47M | 0.00% |
| 2011 | 125.47M | 0.00% |
| 2010 | 125.47M | 0.00% |
Ações em circulação de empresas semelhantes ou concorrentes
| Empresa | Ações em circulação | Diferença | País |
|---|---|---|---|
| 371.00M | 121.89% |
US
|
|
| 705.30M | 321.83% |
US
|
|
| 143.28M | -14.31% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 68.66% |
US
|
